SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CuraSen to Present Phase 2a CuraAX Data at Autonomic Symposium

CuraSen Therapeutics says its president and chief scientific officer, Anthony Ford, will deliver the Burnstock Plenary.

Related stories